RxDoctor Payments Data
★ My doctorsLook up a doctor →

Joseph Russo

Newton Centre, MANPI 1598732240

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $234,068 of the $270,336 with a category attached, or 86.6%. AbbVie accounts for 92.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $114,606 and has fallen 70.2% since, to $34,155 in 2025.

$270,336in general payments, 2019–2025

Across 433 payments — averaging $624.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$250K
  • Galderma Laboratories, L.p.$10K
  • Merz North America, Inc.$10K
  • Revance Therapeutics, Inc.$283
  • Sientra, Inc.$238
  • Solta Medical, A Division Of Bausch Health US, LLC$18
  • plus $15 from 1 others

What the payments were for

  • Consulting fees$13,3405%
  • Speaking & faculty fees$234,06887%
  • Travel & lodging$7,2833%
  • Food & beverage$15,4606%
  • Education$1850%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)356$249,900
Galderma Laboratories, L.p.30$9,996
Merz North America, Inc.34$9,885
Revance Therapeutics, Inc.3$283
Sientra, Inc.8$238
Solta Medical, A Division Of Bausch Health US, LLC1$18
Mentor Worldwide LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →